Industry Symposium 10


13:30-15:00    Room S11

Identifying ADPKD patients with evidence of rapidly progressing disease

Chair: Bertrand Knebelmann, Paris, France

Welcome and introductions
Bertrand Knebelmann, Paris, France
Defining and predicting rapid progression
Yannick Le Meur, Brest, France
The value of prediction
Arlene Chapman, Chicago, USA
Moving towards consensus
Bertrand Knebelmann, Paris, France
Panel discussion and Q&A followed by concluding comments
Bertrand Knebelmann, Paris, France

Organised by OTSUKA PHARMACEUTICAL EUROPE

 

back to the timetable